Search

Search Constraints

You searched for: Author/Creator Boxer, Adam

Search Results

1. Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. Issue 1 (8th January 2020)

2. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease. Issue 2 (23rd October 2014)

3. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease. Issue 12 (6th September 2016)

4. [IC‐P‐186]: AV1451‐PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN?. (1st July 2017)

5. [P2–317]: PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT. (1st July 2017)

7. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study. Issue 6 (14th August 2014)

8. Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. Issue 1 (6th January 2020)

10. [P4–016]: A STUDY TO MODEL RATES OF CHANGE ON NEUROPSYCHOLOGICAL TEST MEASURES IN SUBJECTS DIAGNOSED WITH BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AND HEALTHY SUBJECTS. (1st July 2017)